Storia della carriera di Tim Leaver
Precedenti posizioni note di Tim Leaver
Società | Posizione | Inizio | Fine |
---|---|---|---|
Delphic Diagnostics Ltd.
Delphic Diagnostics Ltd. Medical/Nursing ServicesHealth Services Delphic is a specialist laboratory company with world-leading capabilities in pharmacology and pharmacogenetics. It was the first company in the world to offer an integrated diagnostics and biomarker service in HIV and is now applying that model in hepatitis. It has particular expertise in infectious diseases, including capabilities in study design and in method development and transfer, and a growing clinical trials portfolio. It is planning to apply its expertise to other therapy areas. Delphic is growing, organically and by acquisition, into a specialist biomarker and companion diagnostics company able to support the growing demand for personalised medicine in clinical therapy and in drug development. Its laboratories are certified to ISO, GCLP, CAP and CLIA. It has global reach via its own laboratories in the UK and partner laboratories in Italy, Spain, Greece and Argentina. | Direttore/Membro del Consiglio | 01/12/2009 | 03/10/2012 |
Fondatore | 01/12/2009 | 03/10/2012 | |
Presidente | 01/01/2001 | 01/12/2009 | |
Serono Ltd. | Direttore Finanziario/CFO | - | - |
Formazione di Tim Leaver
University of Warwick | Undergraduate Degree |
Statistiche
Distribuzione geografica
Regno Unito | 4 |
Posizioni
Director/Board Member | 1 |
Founder | 1 |
President | 1 |
Settori
Consumer Services | 2 |
Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Delphic Diagnostics Ltd.
Delphic Diagnostics Ltd. Medical/Nursing ServicesHealth Services Delphic is a specialist laboratory company with world-leading capabilities in pharmacology and pharmacogenetics. It was the first company in the world to offer an integrated diagnostics and biomarker service in HIV and is now applying that model in hepatitis. It has particular expertise in infectious diseases, including capabilities in study design and in method development and transfer, and a growing clinical trials portfolio. It is planning to apply its expertise to other therapy areas. Delphic is growing, organically and by acquisition, into a specialist biomarker and companion diagnostics company able to support the growing demand for personalised medicine in clinical therapy and in drug development. Its laboratories are certified to ISO, GCLP, CAP and CLIA. It has global reach via its own laboratories in the UK and partner laboratories in Italy, Spain, Greece and Argentina. | Health Services |
Serono Ltd. |
- Borsa valori
- Insiders
- Tim Leaver
- Esperienza